ImmunityBio, Inc. develops next-generation cancer therapies and vaccines that complement and amplify the immune system. Our broad, proprietary immunotherapy, NK cell therapy, and vaccine platforms are designed to attack cancer by activating both the innate and adaptive immune system in an orchestrated manner to outsmart the disease and establish “immunological memory” that confers long-term benefit for the patient.